Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBITDA Margin (QoQ) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | -1.00 Mn |
| Mar 31, 2021 | -127,497.00 |
| Dec 31, 2020 | 162,626.00 |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | -1.16 Mn |
| Mar 31, 2020 | -177,825.00 |
| Dec 31, 2019 | 106,424.00 |
| Sep 30, 2019 | -97,493.00 |
| Jun 30, 2019 | 141,240.00 |
| Mar 31, 2019 | 734,520.00 |
| Dec 31, 2018 | -738,605.00 |
| Sep 30, 2018 | 8,617.00 |
| Jun 30, 2018 | -20,350.00 |
| Sep 30, 2017 | 120,857.00 |
| Jun 30, 2017 | -150,613.00 |
| Sep 30, 2016 | 33,860.00 |
| Jun 30, 2016 | -32,890.00 |
| Mar 31, 2016 | -4,152.00 |
| Dec 31, 2015 | 63,642.00 |